Liaoning Cancer Hospital & Institute — Shenyang, Liaoning

Public research footprint of Liaoning Cancer Hospital & Institute, compiled from the ClinicalTrials.gov public registry.

156

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Locally Advanced Breast Cancer (LABC) · Ovarian Cancer · Metastatic Breast Cancer

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT07739758 — A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve… (Not Yet Recruiting)
NCT06792552 — A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Liaoning Cancer Hospital & Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.